How is the Thronson Family Trust UA involved in Trulieve (TCNNF) share ownership?

The filing lists 9,740 Trulieve subordinate voting shares held indirectly through the Thronson Family Trust UA. This indicates a portion of Thronson’s reported equity interest is owned via a trust structure, separate from the 64,543 shares she holds directly in her own name.

Trulieve (TCNNF) director Susan Thronson receives 23,438 RSU equity award

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Thronson Susan reported acquisition or exercise transactions in this Form 4 filing.

Trulieve Cannabis Corp. director Susan Thronson received an equity award in the form of restricted stock units (RSUs). The grant covers 23,438 RSUs, each representing a contingent right to receive one Trulieve subordinate voting share at no cash cost.

The RSUs vest on the earliest of the end of her board service, a change of control of Trulieve, or December 1, 2032. Following this award, Thronson holds 64,543 subordinate voting shares directly and 9,740 shares indirectly through the Thronson Family Trust UA.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Thronson Susan

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Subordinate Voting Shares	23,438	$0.00	--
holding	Subordinate Voting Shares	--	--	--

Holdings After Transaction: Subordinate Voting Shares — 64,543 shares (Direct); Subordinate Voting Shares — 9,740 shares (Indirect, By: Thronson Family Trust UA)

Footnotes (1)

[object Object]

Form 4 Insider Transactions: What Each Field Means →

03/17/2026 - 05:01 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thronson Susan

(Last)

(First)

(Middle)

C/O TRULIEVE CANNABIS CORP.

3494 MARTIN HURST ROAD

(Street)

TALLAHASSEE

32312

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Trulieve Cannabis Corp. [ TRUL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Subordinate Voting Shares	03/13/2026		A		23,438⁽¹⁾	A	$0	64,543	D
Subordinate Voting Shares								9,740	I	By: Thronson Family Trust UA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. The RSUs will vest on the earliest of (i) the end of the reporting person's service on the board of directors of Trulieve, (ii) a change of control of Trulieve, or (iii) December 1, 2032.

	/s/ Eric Powers, as Attorney-in-Fact	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Trulieve Cannabis Corp. (TCNNF) director Susan Thronson report?

Director Susan Thronson reported an equity award of 23,438 restricted stock units. Each RSU represents a contingent right to receive one Trulieve subordinate voting share, increasing her equity-based compensation without an immediate cash outlay or open-market share purchase.

How many Trulieve (TCNNF) shares does Susan Thronson hold after this Form 4 filing?

After the award, Susan Thronson holds 64,543 Trulieve subordinate voting shares directly. The filing also reports 9,740 shares held indirectly through the Thronson Family Trust UA, giving investors a clearer view of her combined direct and indirect equity exposure to the company.

What are the vesting terms of Susan Thronson’s RSU grant at Trulieve (TCNNF)?

The 23,438 RSUs vest on the earliest of three events: the end of Thronson’s service on Trulieve’s board, a change of control of Trulieve, or December 1, 2032. These long-dated conditions align the award with ongoing board service and company control events.

Did Susan Thronson buy or sell Trulieve (TCNNF) shares on the open market in this Form 4?

No open-market buy or sell is reported. The Form 4 shows an acquisition coded as a grant or award, reflecting 23,438 RSUs granted as compensation, rather than a discretionary purchase or sale of Trulieve subordinate voting shares in the public market.